Flow Cytometry – It’s not just for immunologist anymore
Flow cytometry is a widely used method for analyzing the expression of cell surface and intracellular molecules. It can also characterize and define different cell types in a heterogeneous cell population. Moreover, flow cytometry also allows simultaneous multi-parameter analysis of single cells. The growth in flow cytometry market is mainly driven by the combination of technological improvements, growing research activities in life science and increasing clinical application of flow cytometry, such as diagnosis of HIV and cancer. Use of more robust photodetectors and new laser emitters, use of LED lamps as emitter, and changes in analytical capacity (multidimensional analysis software) are examples of recent improvements in flow cytometry. Furthermore, major advancements in flow cytometry revolve around new approaches combining existing technologies with routine laboratory procedures, such as imaging, which makes the acquisition of images of cells possible in real time as they pass by the interrogation point. The use of flow cytometry is also seen mostly in cytology, hematology, immunology, and microbiology, among other research fields.
However, lack of skilled technicians for data interpretation & technology implementation is restraining the adoption of flow cytometry, especially in emerging economies.
The global flow cytometry market was valued at US$ 3.2 Bn in 2016 and is expected to witness a robust CAGR of 10.2 % over the forecast period (2017-2025).
Global Flow Cytometry Market By Region - 2016 (US$ Bn)
Increase in clinical applications of flow cytometry is expected to favor the flow cytometry market
The use of flow cytometry in clinical laboratory has grown substantially due to the development of smaller, user-friendly, less expensive instruments and increasing number of research application such as, immunophenotyping, cell sorting, cell cycle analysis, Apoptosis, cell proliferation assays, and intracellular calcium flux is expected to favor the growth of flow cytometry market. Besides, flow cytometry has a unique ability to investigate large cell populations at the single-cell level. This favors the adoption of flow cytometry for clinical application.
Furthermore, flow cytometry is also gaining attraction in drug discovery and development, which helps transforming every stage of preclinical and clinical development, that guide new product evaluation, selection and monitoring. Flow cytometry increases the probability of success in drug development and also allows for more informed decision making. The demand for flow cytometry is growing at all phases of development from early to late favoring the growth of flow cytometry use in industry for drug development process.
Flow cytometry is also employed in testing of CD4 count in order to treat HIV patients with suitable antiretroviral drugs. The BD Biosciences provides CD4 testing facilities and products. BD Biosciences has 3 different systems, namely, BD FACSCount system, mostly used in emerging economies, owing to its ease of use; the BD FACSCalibur system is used in large-volume labs where over 1,000,000 tests are performed annually, and the BD FACSCanto II system, used for HIV monitoring and other applications.
North America dominates the global flow cytometry market
North America accounts for the largest share in the global flow cytometry market, followed by Europe. This mainly is attributed to research and advancement in technology and wide acceptance of the flow cytometry and rapid growth of the life sciences sector in developed countries such as the U.S. The flow cytometry market is expected to show high growth rate in Asia-Pacific region over the forecast period supported by increasing prevalence of HIV. According to Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, around 49,00,000 HIV infected people aged 15 years and above were living in the Asia Pacific region, which in turn is expected to propel the market growth in Asia Pacific region.
Some major players operating in the flow cytometry market are Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc. and Danaher Corporation.
Flow cytometry is a procedure based on laser technology employed in cell counting, cell sorting, protein engineering and biomarker detection. Flow cytometer are used in cytology, hematology, immunology, and microbiology, among other research fields. Advancements in the technology such as, the use of more robust photodetectors and new laser emitters, the use of LED lamps as emitter, and changes in analytical capacity in flow cytometry are expected to favor growth of the flow cytometry market. This technique allows researchers to get highly specific information about individual cells. The increasing application of flow cytometry in diagnostic test favors the market. For instance the CD4 test for HIV.
Increasing novel application of flow cytometer, such as cytogenomics, proteomics, and marine cell biology, is expected to drive the flow cytometry market in near future. Whereas, increasing demand for flow cytometry in hospitals and diagnostic centers for the effective diagnosis as well as monitoring of diseases supports the growth of market. Moreover, limited availability of technical expertise hampers the growth of flow cytometry market.
Flow cytometry is quite an unexplored field, which is rapidly advancing due to technological advancements in the recent past. The increasing FDA approval for various clinical test favors the growth of flow cytometry market in near future. For instance, in 2017 the use of flow cytometer in detection of leukemia & lymphoma cancers was approved by FDA. Therefore, rising prevalence of HIV and cancer favors the growth of flow cytometer market.
Whereas, number of advantages of flow cytometer over traditional analytical methods such as, ELISA that include the ability of flow cytometer to deliver precise and accurate results in less time, with same price.
Furthermore, in 2017 there were number of product launches, which supports the growth of flow cytometry market in near future. For instance, Beckman Coulter Life Sciences received FDA approval for product named the Navios EX flow cytometer in August 2107.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 30 market data tables and 28 figures on "Flow Cytometry Market” - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.